Education
About Us
Working with TipRanks
Follow Us
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
RESEARCH TOOLSreports
Total Valuation
Pharmaron Beijing Co., Ltd. Class H has a market cap or net worth of €4.64B. The enterprise value is ―.
Market Cap€4.64B
Enterprise Value―
Share Statistics
Pharmaron Beijing Co., Ltd. Class H has 301,537,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding301,537,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmaron Beijing Co., Ltd. Class H’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee574.44K
Profits Per Employee80.21K
Employee Count21,370
Asset Turnover0.51
Inventory Turnover7.23
Valuation Ratios
The current PE Ratio of Pharmaron Beijing Co., Ltd. Class H is 13.20. Pharmaron Beijing Co., Ltd. Class H’s PEG ratio is 6.38.
PE Ratio13.20
PS Ratio0.00
PB Ratio1.59
Price to Fair Value1.74
Price to FCF-439.62
Price to Operating Cash Flow19.22
PEG Ratio6.38
Income Statement
In the last 12 months, Pharmaron Beijing Co., Ltd. Class H had revenue of 12.28B and earned 1.79B in profits. Earnings per share was 1.00.
Revenue12.28B
Gross Profit4.20B
Operating Income2.10B
Pretax Income2.09B
Net Income1.79B
EBITDA3.38B
Earnings Per Share (EPS)1.00
Cash Flow
In the last 12 months, operating cash flow was 1.16B and capital expenditures 0.00, giving a free cash flow of 561.71M billion.
Operating Cash Flow1.16B
Free Cash Flow561.71M
Free Cash Flow per Share1.86
Dividends & Yields
Pharmaron Beijing Co., Ltd. Class H pays an annual dividend of €0.024, resulting in a dividend yield of 1.51%
Dividend Per Share€0.024
Dividend Yield1.51%
Payout Ratio23.64%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.56
52-Week Price Change79.17%
50-Day Moving Average1.63
200-Day Moving Average1.71
Relative Strength Index (RSI)51.24
Average Volume (3m)16.00
Important Dates
Pharmaron Beijing Co., Ltd. Class H upcoming earnings date is Sep 2, 2025, TBA (Not Confirmed).
Last Earnings DateApr 27, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateJul 04, 2025
Financial Position
Pharmaron Beijing Co., Ltd. Class H as a current ratio of 1.80, with Debt / Equity ratio of 39.40%
Current Ratio1.80
Quick Ratio1.54
Debt to Market Cap0.22
Net Debt to EBITDA1.14
Interest Coverage Ratio8.63
Taxes
In the past 12 months, Pharmaron Beijing Co., Ltd. Class H has paid 377.10M in taxes.
Income Tax377.10M
Effective Tax Rate0.18
Enterprise Valuation
Pharmaron Beijing Co., Ltd. Class H EV to EBITDA ratio is 8.13, with an EV/FCF ratio of 51.35.
EV to Sales2.24
EV to EBITDA8.13
EV to Free Cash Flow51.35
EV to Operating Cash Flow10.68
Balance Sheet
Pharmaron Beijing Co., Ltd. Class H has €2.68B in cash and marketable securities with ¥5.53B in debt, giving a net cash position of €2.85B billion.
Cash & Marketable Securities€2.68B
Total Debt¥5.53B
Net Cash€2.85B
Net Cash Per Share€9.47
Tangible Book Value Per Share€5.97
Margins
Gross margin is 34.43%, with operating margin of 17.14%, and net profit margin of 14.61%.
Gross Margin34.43%
Operating Margin17.14%
Pretax Margin17.04%
Net Profit Margin14.61%
EBITDA Margin27.56%
EBIT Margin19.02%
Analyst Forecast
The average price target for Pharmaron Beijing Co., Ltd. Class H is €2.71, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€2.71
Price Target Upside57.56% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―